Long-term cyclophosphamide treatment in a case with serpiginous choroiditis


Creative Commons License

Sahin O. G.

Case Reports in Ophthalmology, vol.1, no.2, pp.71-76, 2010 (Scopus) identifier identifier

  • Publication Type: Article / Article
  • Volume: 1 Issue: 2
  • Publication Date: 2010
  • Doi Number: 10.1159/000321401
  • Journal Name: Case Reports in Ophthalmology
  • Journal Indexes: Scopus
  • Page Numbers: pp.71-76
  • Keywords: Alkylating agent, Cyclophosphamide, Serpiginous choroiditis
  • Middle East Technical University Affiliated: Yes

Abstract

Purpose: To report the effect of long-term therapy with the alkylating agent cyclophosphamide in a case with serpiginous choroiditis and thus to contribute to the previously reported few cases showing the beneficial effect of long-term cyclophosphamide therapy for serpiginous choroiditis. Procedures: Oral cyclophosphamide therapy for 12 months in a case with unilateral active serpiginous choroiditis. Results: The active lesion responded well to long-term therapy with cyclophosphamide without recurrences and significant systemic side-effects. Conclusions: Long-term therapy with cyclophosphamide for serpiginous choroiditis is effective for improving vision and preventing recurrences. © 2010 S. Karger AG, Basel.